These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29480603)

  • 1. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
    Coletta RD; Salo T
    Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal myofibroblasts in oral squamous cell carcinoma and potentially malignant disorders.
    Jayaraj G; Sherlin HJ; Ramani P; Premkumar P; Natesan A
    Indian J Cancer; 2015; 52(1):87-92. PubMed ID: 26837985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K; Metgud R; Gupta J
    J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
    Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
    J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
    Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis.
    Sarode G; Sarode SC; Deshmukh R; Raktade P; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):443-447. PubMed ID: 28029690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
    Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
    J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hinokitiol ablates myofibroblast activation in precancerous oral submucous fibrosis by targeting Snail.
    Yang HW; Lu MY; Chiu YW; Liao YW; Huang YF; Ju Chueh P; Hsieh PL; Yu CC
    Environ Toxicol; 2018 Apr; 33(4):454-462. PubMed ID: 29328529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
    Angadi PV; Krishnapillai R
    Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral potentially malignant disorders: risk of progression to malignancy.
    Speight PM; Khurram SA; Kujan O
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):612-627. PubMed ID: 29396319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
    Müller S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.
    Jayasinghe LA; Peiris PM; Tilakaratne WM; Attygalla AM; Jayasinghe RD; Sitheeque MA; Siriwardena BS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):210-5. PubMed ID: 27422419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentially malignant disorders of the oral mucosa: terminology and classification].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):208-12. PubMed ID: 20739038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without.
    Chaturvedi P; Malik A; Nair D; Nair S; Mishra A; Garg A; Vaishampayan S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):225-230. PubMed ID: 28606826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
    Liao YW; Yu CC; Hsieh PL; Chang YC
    J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
    Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
    BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.